Article Information
History
- May 19, 2020.
Article Versions
- Version 1 (May 6, 2020 - 07:36).
- You are currently viewing Version 2 of this article (May 19, 2020 - 13:30).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Leon Mutesa1,2,
- Pacifique Ndishimye3,2,
- Yvan Butera2,
- Jacob Souopgui1,2,
- Annette Uwineza2,
- Robert Rutayisire2,
- Emile Musoni2,
- Nadine Rujeni2,
- Thierry Nyatanyi2,
- Edouard Ntagwabira2,
- Muhammed Semakula2,
- Clarisse Musanabaganwa2,
- Daniel Nyamwasa2,
- Maurice Ndashimye3,2,
- Eva Ujeneza3,
- Ivan Emile Mwikarago2,
- Claude Mambo Muvunyi2,
- Jean Baptiste Mazarati2,
- Sabin Nsanzimana2,
- Neil Turok3,4,* and
- Wilfred Ndifon3,†
- 1Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda
- 2Rwanda Joint Task Force COVID-19, Kigali, Rwanda
- 3African Institute for Mathematical Sciences, Kigali, Rwanda
- 4Perimeter Institute for Theoretical Physics, 31 Caroline St N, Ontario, Canada
- ↵†wndifon{at}nexteinstein.org
Posted May 19, 2020.
A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence
